PAA 4.88% 21.5¢ pharmaust limited

PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-568

  1. 1,212 Posts.
    lightbulb Created with Sketch. 355
    While most of my holding are red, PAA is showing sign of recovery. Very small volumes though but PAA is significantly undervalued. As the management has resolved almost all pending issues, next suit of news announcement will start value addition.

    I'm counting a lot on this new management as they have made a U-turn in very short time period. I hope year 2025 could be one of the best year of PAA, heading towards the commercialisation of MPL
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.